サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1777666

獣医循環器学の世界市場

Veterinary Cardiology

出版日
ページ情報
英文 466 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.79円
獣医循環器学の世界市場
出版日: 2025年07月28日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 466 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

獣医循環器学の世界市場は2030年までに米国で42億米ドルに達する見込み

2024年に27億米ドルと推定される獣医循環器学の世界市場は、2024年から2030年にかけてCAGR 7.5%で成長し、2030年には42億米ドルに達すると予測されます。本レポートで分析されているセグメントの1つであるコンパニオンアニマルは、CAGR 8.8%を記録し、分析期間終了時には28億米ドルに達すると予想されています。生産動物セグメントの成長率は、分析期間中CAGR 5.0％と推定されます。

米国市場は7億3,740万米ドルと推定される一方、中国はCAGR 11.9％で成長すると予測される

米国の獣医循環器学市場は、2024年に7億3,740万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに8億9,360万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは11.9%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.6%と7.3%と予測されています。欧州では、ドイツがCAGR 4.9%で成長すると予測されています。

世界の獣医循環器学市場- 主要動向と促進要因のまとめ

なぜ獣医循環器学はコンパニオンアニマルヘルスケアの柱になりつつあるのか？

獣医循環器学は、コンパニオンアニマルにおける心臓関連疾患の有病率の増加と、早期診断と継続的な心臓ケアの重要性に対する飼い主の意識の高まりにより、動物ヘルスケアにおける重要な専門分野として台頭してきています。栄養状態の改善、予防医療、先進医療によりペットの寿命が延びるにつれ、うっ血性心不全、不整脈、弁膜症、先天異常など、加齢に伴う心血管系疾患が一般的になってきています。キャバリア・キング・チャールズ・スパニエル、ボクサー、ドーベルマン・ピンシャーなどの犬種や特定の猫種は、遺伝的に心臓に問題を抱えやすいため、専門的な治療が必要となります。獣医の心臓専門医も一般開業医も、心エコー、心電図（ECG）、X線画像、心臓バイオマーカー検査などの診断を必要とする動物の症例数が増加しています。ペットの飼い主は、動物を家族の一員と考えるようになり、生活の質を向上させ、寿命を延ばすために、高度な診断や治療介入をより積極的に行うようになっています。このように動物の健康や専門的なケアを重視する傾向が強まっているため、世界中の都市部の診療所、専門病院、学術的な動物病院において、獣医循環器学サービスに対する需要が大幅に拡大しています。

診断と画像診断における技術革新は、動物の心臓ケアをどのように向上させているか？

技術革新は獣医循環器学の形を変え、動物の心臓血管疾患の早期発見、より正確な診断、より良いモニタリングを可能にしています。最新の心エコー装置は現在、獣医療用に調整されたドップラーベースの高解像度画像を提供し、臨床医が血流、弁機能、心室寸法を高精度で評価できるようになっています。ポータブルでワイヤレスな心電図システムにより、臨床現場や自宅での心拍解析が容易になり、一般診療所や移動サービスでの診断へのアクセスが向上しています。NT-proBNPやトロポニンなどの心臓バイオマーカーは、心疾患のスクリーニング、病期分類、モニタリングにますます利用されるようになっており、画像診断を低侵襲で補完しています。3D心エコー、コンピュータ断層撮影（CT）、磁気共鳴画像法（MRI）のような高度な画像診断ツールは、特に複雑な症例に対して、動物病院紹介センターで普及しつつあります。遠隔医療も獣医循環器学で重要な役割を果たすようになってきており、開業医が遠隔で専門医と相談したり、心電図やエコーの結果を迅速に解釈したりできるようになってきています。このような技術開発は、ワークフローを合理化し、臨床の精度を高め、最終的には、より効果的な管理と獣医心臓病患者の転帰の改善に貢献しています。

なぜ動物病院や専門病院は心臓病学サービスを拡大しているのでしょうか？

動物病院、専門病院、および学術センターは、専門的治療に対する需要の高まりに対応し、複雑な症例に対するフルサービスの統合治療を提供するために、心臓病学サービスへの投資を増やしています。一般的な動物病院では、聴診トレーニング、ハンドヘルド超音波装置、心電図などの基本的な心臓スクリーニング・ツールを健康診断や麻酔前スクリーニングに取り入れ、心疾患の早期徴候の発見に役立てています。紹介病院や専門病院は、さらに一歩進んで、認定専門医と最新鋭の診断室を備えた心臓病専門部門を設立しています。このようなセンターでは、診断だけでなく、長期的な薬物療法、ペースメーカー植え込み、体液管理プロトコル、必要な場合には外科的介入により、慢性心疾患の管理も行っています。大学獣医学部は心臓学のカリキュラムを強化し、比較心臓学、薬剤開発、先天性心疾患修復の研究を拡大しています。さらに、製薬企業や医療機器企業との協力により、小動物用に調整された新しい治療法の開発が進んでいます。高度な心臓治療を提供する競合クリニックは、ペットの飼い主から深く評価され、しばしば再診、継続的なモニタリング、個別化された治療計画を必要とするペット医療の成長分野に取り組むことで競争力を獲得しており、その結果、顧客との関係が強化され、患者の生涯価値が向上しています。

獣医循環器学市場の世界的成長の原動力は？

獣医循環器学市場の成長は、ペット数動態、技術進歩、臨床革新、高度な動物ケアへの投資意欲の高まりなど、相互に関連するいくつかの要因によって牽引されています。重要な促進要因は、ペットの飼育数の世界の増加とペットの人間化の動向の高まりであり、心臓病のような慢性疾患や加齢に関連する疾患に対する意識の高まりにつながっています。より正確で安価な診断ツールが利用できるようになったことで、一般開業医は患者をスクリーニングし、疾患サイクルの早い段階で心臓の専門的な評価を受けさせることができるようになりました。動物用医薬品、特にACE阻害薬、β遮断薬、利尿薬、新規心臓治療薬などの分野の進歩は、心臓病のより効果的な長期管理を可能にしています。専門医療施設や獣医循環器学研修プログラムの拡大は、特に都市部における専門医へのアクセスのギャップを埋めるのに役立っています。さらに、ペット保険が普及したことで、高度な心臓治療がより多くの顧客にとって経済的に利用しやすくなっています。研究協力や臨床試験も、薬剤開発や治療プロトコルを加速させています。これらの要因が相まって、獣医循環器学はニッチな専門分野から総合的なペット・ヘルスケアの主流分野へと変貌を遂げつつあり、クリニックの構造、獣医専門家の訓練方法、ペットの健康管理方法への影響力は今後ますます大きくなっていくと思われます。

セグメント

動物タイプ（コンパニオンアニマル、生産動物）;製品（医薬品、診断薬）;適応症（うっ血性心不全、心筋疾患、不整脈、その他）;エンドユーザー（動物病院＆クリニック、その他）

調査対象企業の例

  • ALBA Medical Systems, Inc.
  • Antech Diagnostics
  • Boehringer Ingelheim International
  • Bionet America
  • Ceva Sante Animale
  • Cronus Pharma
  • Dextronix
  • Esaote SpA
  • FUJIFILM Holdings Corporation
  • General Electric Company
  • IDEXX Laboratories
  • IMV Technologies
  • Infiniti Medical
  • Jurox
  • Medtronic
  • Merck & Co., Inc.
  • Patterson Veterinary
  • Pet Cardiology
  • RHC Medical
  • Scapa Healthcare

AI統合

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP33249

Global Veterinary Cardiology Market to Reach US$4.2 Billion by 2030

The global market for Veterinary Cardiology estimated at US$2.7 Billion in the year 2024, is expected to reach US$4.2 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Companion Animals, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$2.8 Billion by the end of the analysis period. Growth in the Production Animals segment is estimated at 5.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$737.4 Million While China is Forecast to Grow at 11.9% CAGR

The Veterinary Cardiology market in the U.S. is estimated at US$737.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$893.6 Million by the year 2030 trailing a CAGR of 11.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 7.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Global Veterinary Cardiology Market - Key Trends & Drivers Summarized

Why Is Veterinary Cardiology Becoming a Pillar of Companion Animal Healthcare?

Veterinary cardiology is emerging as a crucial specialty in animal healthcare, driven by the increasing prevalence of heart-related conditions in companion animals and rising awareness among pet owners about the importance of early diagnosis and ongoing cardiac care. As pets live longer due to better nutrition, preventive care, and advanced medical treatments, age-related cardiovascular diseases-including congestive heart failure, arrhythmias, valve disorders, and congenital anomalies-are becoming more common. Dog breeds such as Cavalier King Charles Spaniels, Boxers, and Doberman Pinschers, as well as certain cat breeds, are genetically predisposed to heart issues, necessitating specialized care. Veterinary cardiologists and general practitioners alike are seeing a growing caseload of animals requiring diagnostics like echocardiography, electrocardiograms (ECGs), radiographic imaging, and cardiac biomarker testing. Pet owners, increasingly viewing their animals as family members, are more willing to pursue advanced diagnostic and therapeutic interventions to improve quality of life and extend longevity. This growing emphasis on animal wellness and specialized care is significantly expanding the demand for veterinary cardiology services across urban clinics, specialty hospitals, and academic veterinary centers worldwide.

How Are Innovations in Diagnostics and Imaging Enhancing Cardiac Care for Animals?

Technological innovation is reshaping veterinary cardiology, enabling earlier detection, more accurate diagnosis, and better monitoring of cardiovascular diseases in animals. Modern echocardiography machines now offer high-resolution, Doppler-based imaging tailored for veterinary use, allowing clinicians to assess blood flow, valve function, and chamber dimensions with high precision. Portable and wireless ECG systems are making it easier to perform heart rhythm analysis in clinical or even home-based settings, improving access to diagnostics in general practices and mobile services. Cardiac biomarkers such as NT-proBNP and troponin are being increasingly utilized for screening, staging, and monitoring heart disease, providing a minimally invasive complement to imaging diagnostics. Advanced imaging tools like 3D echocardiography, computed tomography (CT), and magnetic resonance imaging (MRI) are becoming more prevalent in veterinary referral centers, especially for complex cases. Telemedicine is also playing a growing role in veterinary cardiology, enabling practitioners to consult with specialists remotely and receive rapid interpretations of ECGs or echo results. These technological developments are streamlining workflows, enhancing clinical accuracy, and ultimately contributing to more effective management and improved outcomes in veterinary cardiac patients.

Why Are Veterinary Clinics and Specialty Hospitals Expanding Cardiology Services?

Veterinary clinics, specialty hospitals, and academic centers are increasingly investing in cardiology services to meet rising demand for specialized care and to offer full-service, integrated treatment for complex cases. General veterinary practices are incorporating basic cardiac screening tools-such as auscultation training, handheld ultrasound devices, and ECGs-into wellness exams and pre-anesthetic screenings, helping to catch early signs of cardiac disease. Referral and specialty hospitals are going a step further, establishing dedicated cardiology departments with board-certified specialists and state-of-the-art diagnostic suites. These centers are not only diagnosing but also managing chronic cardiac conditions with long-term pharmacologic therapy, pacemaker implantation, fluid management protocols, and surgical interventions when needed. Academic veterinary schools are strengthening cardiology curricula and expanding research in comparative cardiology, drug development, and congenital heart defect repair. Additionally, collaboration with pharmaceutical and medical device companies is leading to the development of new treatment options tailored for small animals. Clinics offering advanced cardiac care are gaining a competitive edge by addressing a growing segment of pet healthcare that is deeply valued by pet owners and often requires repeat visits, ongoing monitoring, and personalized treatment plans-resulting in stronger client relationships and higher lifetime patient value.

What’s Driving the Global Growth of the Veterinary Cardiology Market?

The growth in the veterinary cardiology market is driven by several interrelated factors tied to pet demographics, technological progress, clinical innovation, and increasing consumer willingness to invest in advanced animal care. A significant driver is the global rise in pet ownership and the growing trend of pet humanization, which has led to greater awareness of chronic and age-related conditions like heart disease. The availability of more accurate and affordable diagnostic tools is empowering general practitioners to screen and refer patients for specialized cardiac evaluations earlier in the disease cycle. Advancements in veterinary pharmaceuticals-especially in areas like ACE inhibitors, beta blockers, diuretics, and novel heart medications-are enabling more effective long-term management of cardiac conditions. The expansion of specialty care facilities and veterinary cardiology training programs is helping to bridge the gap in specialist access, particularly in urban centers. Furthermore, the growth of pet insurance coverage is making advanced cardiac care financially accessible to a larger client base. Research collaborations and clinical trials are also accelerating drug development and treatment protocols. Together, these factors are propelling veterinary cardiology from a niche specialty to a mainstream component of comprehensive pet healthcare, with growing influence on how clinics are structured, how veterinary professionals are trained, and how pet health is managed in the years to come.

SCOPE OF STUDY:

The report analyzes the Veterinary Cardiology market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Animal Type (Companion Animals, Production Animals); Product (Pharmaceuticals, Diagnostics); Indication (Congestive Heart Failure, Myocardial Disease, Arrhythmias, Others); End-Use (Veterinary Hospitals & Clinics, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

  • ALBA Medical Systems, Inc.
  • Antech Diagnostics
  • Boehringer Ingelheim International
  • Bionet America
  • Ceva Sante Animale
  • Cronus Pharma
  • Dextronix
  • Esaote SpA
  • FUJIFILM Holdings Corporation
  • General Electric Company
  • IDEXX Laboratories
  • IMV Technologies
  • Infiniti Medical
  • Jurox
  • Medtronic
  • Merck & Co., Inc.
  • Patterson Veterinary
  • Pet Cardiology
  • RHC Medical
  • Scapa Healthcare

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Veterinary Cardiology - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cardiac Conditions in Aging Pets Throws the Spotlight on Specialized Veterinary Cardiology Services
    • Advancements in Diagnostic Imaging and ECG Technologies Strengthen the Business Case for Cardiology Integration
    • Increased Pet Owner Awareness of Heart Health Propels Growth in Preventive Cardiac Screening and Monitoring
    • Here's How Breed-Specific Genetic Predispositions Are Driving Adoption of Early Cardiac Evaluations
    • Expansion of Veterinary Specialty Clinics and Referral Hospitals Accelerates Demand for Cardiology Equipment
    • Integration of Telecardiology and Remote Diagnostics Expands Access to Expertise in Underserved Regions
    • Growth in Companion Animal Lifespans Sustains Long-Term Demand for Chronic Cardiac Disease Management
    • Widespread Adoption of Echocardiography and Doppler Imaging Enhances Diagnostic Accuracy and Clinical Confidence
    • Here's the Story Behind the Surge in Demand for Cardiac Medications and Evidence-Based Treatment Protocols
    • Increased Availability of Pet Insurance Encourages Pursuit of Advanced and Costlier Cardiology Procedures
    • Development of Wearable Monitoring Devices and AI Diagnostics Accelerates Innovation in Cardiac Care
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Veterinary Cardiology Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Veterinary Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Veterinary Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Veterinary Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Companion Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Companion Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Companion Animals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Production Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Production Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Production Animals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Veterinary Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Veterinary Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Veterinary Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Congestive Heart Failure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Congestive Heart Failure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Congestive Heart Failure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Myocardial Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Myocardial Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Myocardial Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Arrhythmias by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Arrhythmias by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Arrhythmias by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Veterinary Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • JAPAN
    • Veterinary Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • CHINA
    • Veterinary Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 71: China Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • EUROPE
    • Veterinary Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Veterinary Cardiology by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Veterinary Cardiology by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Veterinary Cardiology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • FRANCE
    • Veterinary Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 98: France Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: France 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: France 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 104: France Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: France Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: France 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 107: France Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: France Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: France 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • GERMANY
    • Veterinary Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Germany 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 113: Germany Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Germany Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Germany 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 116: Germany Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Germany Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Germany 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 119: Germany Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Germany 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 122: Italy Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Italy Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Italy 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 125: Italy Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Italy Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Italy 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 128: Italy Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Italy Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Italy 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 131: Italy Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Italy 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Veterinary Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 134: UK Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: UK Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: UK 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 137: UK Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: UK Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: UK 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 140: UK Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: UK Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: UK 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 143: UK Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: UK 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 146: Spain Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Spain Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Spain 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 149: Spain Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Spain Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Spain 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 152: Spain Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Spain Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Spain 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 155: Spain Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Spain Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Spain 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 158: Russia Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Russia Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Russia 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 161: Russia Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Russia Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Russia 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 164: Russia Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Russia Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Russia 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 167: Russia Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Russia Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Russia 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 170: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Europe Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Rest of Europe 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Rest of Europe Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Rest of Europe 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Europe Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Rest of Europe 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Europe Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Europe 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Veterinary Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 182: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Cardiology by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 183: Asia-Pacific Historic Review for Veterinary Cardiology by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Asia-Pacific 15-Year Perspective for Veterinary Cardiology by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Asia-Pacific Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Asia-Pacific 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Asia-Pacific Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Asia-Pacific 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Asia-Pacific Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Asia-Pacific 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Asia-Pacific Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Asia-Pacific 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Veterinary Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 197: Australia Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Australia Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Australia 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 200: Australia Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Australia Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Australia 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 203: Australia Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Australia Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Australia 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 206: Australia Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Australia Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Australia 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • INDIA
    • Veterinary Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 209: India Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: India Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: India 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 212: India Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: India Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: India 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 215: India Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: India Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: India 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 218: India Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: India Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: India 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 221: South Korea Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: South Korea Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: South Korea 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 224: South Korea Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: South Korea Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: South Korea 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 227: South Korea Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: South Korea Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: South Korea 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 230: South Korea Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: South Korea Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: South Korea 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 233: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Asia-Pacific Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Asia-Pacific 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Asia-Pacific Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Asia-Pacific 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Asia-Pacific Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Asia-Pacific Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Veterinary Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 245: Latin America Recent Past, Current & Future Analysis for Veterinary Cardiology by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 246: Latin America Historic Review for Veterinary Cardiology by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Latin America 15-Year Perspective for Veterinary Cardiology by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 248: Latin America Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Latin America Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Latin America 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 251: Latin America Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Latin America Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Latin America 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 254: Latin America Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Latin America Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Latin America 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 257: Latin America Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Latin America Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Latin America 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 260: Argentina Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Argentina Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Argentina 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 263: Argentina Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Argentina Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Argentina 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 266: Argentina Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Argentina Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Argentina 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 269: Argentina Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Argentina Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Argentina 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 272: Brazil Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Brazil Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Brazil 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 275: Brazil Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Brazil Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Brazil 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 278: Brazil Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Brazil Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Brazil 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 281: Brazil Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Brazil Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Brazil 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 284: Mexico Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Mexico Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Mexico 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 287: Mexico Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Mexico Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Mexico 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 290: Mexico Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Mexico Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Mexico 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 293: Mexico Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Mexico Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Mexico 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 296: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Latin America Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Latin America 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Latin America Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Latin America 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Latin America Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Latin America 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Latin America Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Rest of Latin America 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Veterinary Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 308: Middle East Recent Past, Current & Future Analysis for Veterinary Cardiology by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 309: Middle East Historic Review for Veterinary Cardiology by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: Middle East 15-Year Perspective for Veterinary Cardiology by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 311: Middle East Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Middle East Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 313: Middle East 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 314: Middle East Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Middle East Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 316: Middle East 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 317: Middle East Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Middle East Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 319: Middle East 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 320: Middle East Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Middle East Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 322: Middle East 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 323: Iran Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Iran Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 325: Iran 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 326: Iran Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Iran Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 328: Iran 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 329: Iran Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Iran Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 331: Iran 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 332: Iran Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Iran Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 334: Iran 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 335: Israel Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Israel Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 337: Israel 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 338: Israel Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Israel Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 340: Israel 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 341: Israel Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Israel Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 343: Israel 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 344: Israel Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Israel Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 346: Israel 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 347: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Saudi Arabia Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 349: Saudi Arabia 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 350: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Saudi Arabia Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 352: Saudi Arabia 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Saudi Arabia Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 355: Saudi Arabia 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Saudi Arabia Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 358: Saudi Arabia 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 359: UAE Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 360: UAE Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 361: UAE 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 362: UAE Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 363: UAE Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 364: UAE 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 365: UAE Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 366: UAE Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 367: UAE 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 368: UAE Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 369: UAE Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 370: UAE 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 371: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 372: Rest of Middle East Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 373: Rest of Middle East 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 374: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 375: Rest of Middle East Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 376: Rest of Middle East 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 378: Rest of Middle East Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 379: Rest of Middle East 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 381: Rest of Middle East Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 382: Rest of Middle East 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • AFRICA
    • Veterinary Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 383: Africa Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 384: Africa Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 385: Africa 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 386: Africa Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Africa Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 388: Africa 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 389: Africa Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Africa Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 391: Africa 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 392: Africa Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Africa Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 394: Africa 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030

IV. COMPETITION